Abstract
The worldwide increase in infections caused by extended-spectrum beta-lactamase-(ESBL) and AmpC-producing Enterobacteriaceae (ESBL-E) is a concern. Surveillance is extensive in Europe, North America, and Asia. Yet, there is no summarizing surveillance in Africa. This study aimed to perform a preliminary investigation on the prevalence of ESBL-E in the northeastern part of Nigeria. However, of the 60 samples collected, we were able to culture 15 Escherichia coli and 7 Klebsiella spp. only. In the collection of clinical hospital samples, we found eight of 15 E. coli isolates to be ESBL (53%) and two out of seven Klebsiella spp. to be ESBL/AmpC (29%). Due to the limitations of this study, our findings cannot take a broad view on the prevalence of ESBL-E, in Nigeria and other parts of Africa. Yet, to know which genes encode ESBL in Nigeria, and to know exact prevalence of every ESBL gene would be of importance. were ESBL-screening test-positive. ESBL-or AmpC production was phenotypically confirmed by the MAST test, performed as a combined-disk method, using disks containing cefpodoxime ±ESBL and/ or AmpC inhibitors (MAST®, Merseyside, UK) (Hertz et al., 2015) .
K E Y W O R D S
Of the 60 samples collected, one was without any bacterial growth. In the remaining 59 samples, we were able to culture 15 E. coli and 7 Klebsiella spp. (6 K. pneumoniae and 1 Klebsiella oxytoca) only. Results of antibiotic susceptibility testing are found in Figure 1 . Of the 15 identified E. coli, eight produced ESBL, but none produced AmpC. The majority of E. coli were resistant to trimethoprim (n = 13), sulfamethizol (n = 13), and ciprofloxacin (n = 10), yet none were resistant to mecillinam (n = 0) or nitrofurantoin (n = 0) (Figure 1 ). Of the seven Klebsiella spp., one produced ESBL and one produced AmpC. Besides resistance to ampicillin, which is intrinsic in K. pneumoniae and K. oxytoca, resistance was low among Klebsiella spp. None of the isolates were found to be carbapenemase producers.
Thus, in the collection of clinical hospital samples from Bauchi, Nigeria, we found eight of 15 E. coli isolates to be ESBL (53%) and two out of seven Klebsiella spp. to be ESBL/AmpC (29%).
Our study has several limitations. First, all bacterial cultures were transferred from Nigeria to Denmark without temperature control and most of these cultures were therefore contaminated. Second, only 22 bacterial isolates were left why we cannot generalize on the prevalence of ESBL-and AmpC-producing Enterobacteriaceae in Nigeria. Third, we have not considered selection bias.
Due to the limitations of this study, our findings cannot take a broad view on the prevalence of ESBL-E in Nigeria and other parts of Africa. Yet, to know which genes encode ESBL in Nigeria, and to know exact prevalence of every ESBL gene would be of importance. Such a study must take identification of isolates in Nigeria and subsequent transportation of isolates into consideration.
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F I G U R E 1 Resistance pattern for the 22 samples found as monoculture of Escherichia coli or Klebsiella spp. Here, the pathogens were considered to be the true pathogen. The number shown is the number of isolates resistant to the antibiotic. Eight E. coli isolates were found to be ESBL producing and two Klebsiella pneumoniae isolates were ESBL and AmpC producing, respectively. ESBL: extended-spectrum beta-lactamase risks and was in no way at the expense of the subject. All data were anonymized. Thus, no ethical approval or consent was necessary.
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